PERSPECTA

News from every angle

← Back to headlines

Morgan Stanley Increases Price Goal on Alnylam Pharmaceuticals

Morgan Stanley has raised its price target for Alnylam Pharmaceuticals, Inc. (ALNY) stock.

13 May, 17:55 — 13 May, 17:55
PostShare

Sources

Showing 1 of 1 sources
YahooMostly Factual104d ago

Morgan Stanley Increases Price Goal on Alnylam Pharmaceuticals, Inc. (ALNY)

Read full article →

Related Stories

Treasury Secretary Bessent's Bond Strategy Faces Scrutiny and Criticism

2h ago

Richtech Robotics Announces Stock Repurchase Program, Shares Rise

6h ago

Analyst Reactions to Dick's Sporting Goods Stock Decline Following Earnings

6h ago

Apollo, KKR, and IFM Investors Finalists in AB Ports Stake Sale

6h ago